Genesis Healthcare Inc Stock Forecast for 2023 - 2025 - 2030
Updated on 02/05/2023
Genesis Healthcare Inc Stock Forecast and Price Target
If the average price target of $25.00 set by two distinguished experts for Genesis Healthcare Inc over the past few weeks is reached this year, there would be a potential upside of approximately 17.37% from the last closing price in February, 2023. This potential increase is based on a high estimate of $29.00 and a low estimate of $24.00. Even if not interested in GEN stock, you may want to be aware of its competitors.
17.37% Upside
Genesis Healthcare Inc Fair Value Forecast for 2023 - 2025 - 2030
In the last three years, Genesis Healthcare Inc's Price has grown from $24.07 to $26.50 – a 10.06% increase. Next year, analysts are expecting Fair Value to reach $28.77 – an increase of 8.57%. Over the next eight years, the forecast is for Fair Value to grow by 24.89%.
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|
| MSFT Stock Forecast | Microsoft | Outperform |
18
|
$258.35 | $285.81 | 8.38% |
| CRM Stock Forecast | salesforce.com, inc. | Outperform |
16
|
$171.04 | $189.99 | 8.16% |
| INTU Stock Forecast | Intuit | Outperform |
10
|
$423.76 | $476.40 | 11.86% |
| NOW Stock Forecast | ServiceNow | Buy |
14
|
$472.22 | $521.22 | 8.00% |
| ATVI Stock Forecast | Activision Blizzard | Outperform |
17
|
$75.24 | $92.04 | 26.26% |
Genesis Healthcare Inc Revenue Forecast for 2023 - 2025 - 2030
In the last three years, Genesis Healthcare Inc's Revenue has grown from $2.46B to $2.80B – a 13.84% increase. Next year, analysts are expecting Revenue to reach $2.98B – an increase of 6.71%. Over the next eight years, the forecast is for Revenue to grow by 18.22%.
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|
| SNPS Stock Forecast | Synopsys | Buy |
16
|
$361.44 | $414.43 | 16.20% |
| EA Stock Forecast | Electronic Arts | Outperform |
16
|
$113.92 | $148.57 | 31.67% |
| NUAN Stock Forecast | Nuance Communications | - |
12
|
$55.99 | $57.00 | -62.49% |
Genesis Healthcare Inc Dividend per Share Forecast for 2023 - 2025 - 2030
In the last three years, Genesis Healthcare Inc's Dividend per Share has grown by 66.67%, rising from $0.30 to $0.50. According to 2 prominent analysts, Genesis Healthcare Inc's Dividend per Share will fall by 0.00% in the next year, reaching $0.50. Over the next eight years, experts predict that Genesis Healthcare Inc's Dividend per Share will grow at a rate of 2.53%.
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|
| TTWO Stock Forecast | Take-Two Interactive Software | Outperform |
12
|
$109.28 | $136.07 | 20.79% |
| PTC Stock Forecast | PTC | Outperform |
15
|
$130.55 | $142.86 | 11.07% |
| SPLK Stock Forecast | Splunk | Outperform |
7
|
$104.57 | $123.41 | 4.24% |
Genesis Healthcare Inc Free Cash Flow Forecast for 2023 - 2025 - 2030
In the last three years, Genesis Healthcare Inc's Free Cash Flow has seen a drop from $1.29B to $968.00M – a 24.84% decrease. In the next year, analysts believe that Free Cash Flow will reach $1.17B – an increase of 21.18%. For the next eight years, the forecast is for Free Cash Flow to grow by 27.09%.
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|
| SSNC Stock Forecast | SS&C Technologies Holdings | Outperform |
18
|
$61.62 | $65.55 | 5.49% |
| CTXS Stock Forecast | Citrix Systems | - |
13
|
$103.90 | $105.86 | -1.59% |
| NasdaqGS:AZPN Stock Forecast | AspenTech | - |
16
|
$166.30 | $152.67 | 49.75% |
Genesis Healthcare Inc Net Income Forecast for 2023 - 2025 - 2030
In the last three years, Genesis Healthcare Inc's Net Income has grown by 2596.77%, rising from $31.00M to $836.00M. For next year, analysts predict Net Income of $1.11B, which would mean an increase of 32.94%. Over the next eight years, experts predict that Genesis Healthcare Inc's Net Income will grow at a rate of 51.62%.
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|
| PFPT Stock Forecast | Proofpoint | - |
10
|
$175.90 | $172.31 | 2.03% |
| ZNGA Stock Forecast | Zynga | Hold |
14
|
$8.18 | $12.04 | 22.25% |
| CHNG Stock Forecast | Change Healthcare | Hold |
11
|
$27.49 | $0.00 | -6.33% |
Genesis Healthcare Inc EBITDA Forecast for 2023 - 2025 - 2030
Genesis Healthcare Inc's EBITDA has grown In the last three years, rising from $596.00M to $1.32B – a growth of 121.81%. In the next year, analysts believe that EBITDA will reach $1.56B – an increase of 17.82%. For the next eight years, experts predict that Genesis Healthcare Inc's EBITDA will grow at a rate of 28.94%.
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|
| RP Stock Forecast | RealPage | - |
16
|
$0.13 | $94.88 | 74023.08% |
| GWRE Stock Forecast | Guidewire Software | Outperform |
2
|
$75.80 | $79.58 | 7.52% |
| NATI Stock Forecast | National Instruments | Outperform |
18
|
$53.50 | $48.29 | -10.28% |
Genesis Healthcare Inc EBIT Forecast for 2023 - 2025 - 2030
Genesis Healthcare Inc's EBIT has seen impressive growth In the last three years, rising from $379.00M to $1.22B – a growth of 222.16%. In the next year, analysts believe that EBIT will reach $1.56B – an increase of 27.78%. For the next eight years, the forecast is for EBIT to grow by 32.17%.
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|
| ESTC Stock Forecast | Elastic N.V. | Outperform |
8
|
$61.30 | $0.00 | 109.62% |
| QLYS Stock Forecast | Qualys | Hold |
16
|
$122.97 | $140.27 | 2.06% |
| ALTR Stock Forecast | Altair Engineering | Outperform |
15
|
$57.77 | $0.00 | 45.40% |
Genesis Healthcare Inc EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last three years, Genesis Healthcare Inc's EPS has grown from $1.59 to $1.75 – a 10.06% increase. Next year, analysts are expecting EPS to reach $1.90 – an increase of 8.57%. Over the next eight years, the forecast is for EPS to grow by 24.89%.
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|
| ALU Stock Forecast | Altium | Hold |
18
|
$167.50 | $31.62 | -79.70% |
| NCR Stock Forecast | NCR | Buy |
15
|
$28.39 | $53.86 | 51.46% |
| PEGA Stock Forecast | Pegasystems | Hold |
8
|
$40.98 | $58.00 | 22.01% |